MDNA - Medicenna Therapeutics reports Q2 results
Medicenna Therapeutics (MDNA): FQ2 GAAP EPS of -C$0.08.Cash, cash equivalents and marketable securities of C$34.2M.Press Release
For further details see:
Medicenna Therapeutics reports Q2 resultsLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | Medicenna Therapeutics Corp. |
| Stock Symbol: | MDNA |
| Market: | NASDAQ |
Get MDNA Alerts
News, Short Squeeze, Breakout and More Instantly...